GSV-89513-27601
3 vaccinations
4 coded responses
16 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 371 / TN
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Pfizer-BioNTech
-
2021-04-07
Survey response — day 0, dose 1MedDRA: Hyperhidrosis — Feeling: Fair · Site: Redness · Muscle or body achesFree text: SweatyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Survey response — days 1–6 daily, dose 1MedDRA: Injection site nodule — Feeling: Good · Site: Redness · Muscle or body achesFree text: Knotting of the injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-13
- 2021-04-14
-
2021-04-21
Survey response — day 14, dose 1MedDRA: Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: UTIMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-28
Dose 2 — Pfizer-BioNTech
-
2021-04-28
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness · Chills, Fatigue or tirednessAdult check-in
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: Pregnancy test positive — Feeling: Fair · Fever · Chills, Fatigue or tirednessFree text: Tested positive for pregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-05-01
- 2021-05-03
- 2021-05-05
- 2022-02-25
-
2022-02-25
Call successfulDoes not wish to fill out VAERS report
-
2022-08-01
Dose 3 — Pfizer-BioNTech
-
2022-08-01
Health check-in — day 0, dose 3Feeling: Fair · Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-08-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2022-08-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
1 wait over 3 months for a first call
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Sweaty
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Knotting of the injection
Release 7 — day 14, dose 1
Symptoms: UTI
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Tested positive for pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Injection site nodule | ✓ | ✓ | ✓ |
| SRO | Pregnancy test positive | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release